PreciThera, Inc.
Industry
- Biotechnology
See more in Biomedtracker
Latest on PreciThera, Inc.
In Vivo
• By Amanda Micklus and Maureen Riordan
Financings Third-quarter 2017 biopharma financing reached $12.5 billion, just a 6% decrease from the previous quarter's $13.4 billion. ( See Exhibit 1. ) The most money was raised in the follow-on pub
Scrip
• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner
Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar